288 related articles for article (PubMed ID: 27571719)
1. Primary biliary cholangitis, let's try to keep the new nomenclature correct!
Harinck F
Neth J Med; 2016 Jul; 74(6):229-30. PubMed ID: 27571719
[No Abstract] [Full Text] [Related]
2. [Primary biliary cirrhosis and ursodeoxycholic acid therapy].
Makino I
Nihon Naika Gakkai Zasshi; 1996 Mar; 85(3):399-403. PubMed ID: 8691003
[No Abstract] [Full Text] [Related]
3. The Evolving Landscape of Primary Biliary Cholangitis.
John BV
Clin Liver Dis; 2022 Nov; 26(4):xiii-xv. PubMed ID: 36270729
[No Abstract] [Full Text] [Related]
4. Fibrates for Primary Biliary Cholangitis: What's All the Hype?
Levy C
Ann Hepatol; 2017; 16(5):704-706. PubMed ID: 28809729
[TBL] [Abstract][Full Text] [Related]
5. Ursodeoxycholic acid for primary biliary cirrhosis.
Lindor KD; Poupon R; Poupon R; Heathcote EJ; Therneau T
Lancet; 2000 Feb; 355(9204):657-8. PubMed ID: 10697011
[No Abstract] [Full Text] [Related]
6. Pediatric-onset primary biliary cholangitis.
Liberal R; Gaspar R; Macedo G
Dig Liver Dis; 2019 Jul; 51(7):1064-1065. PubMed ID: 31155491
[No Abstract] [Full Text] [Related]
7. [Treatment of cholestatic liver diseases with ursodeoxycholic acid].
Boberg KM; Schrumpf E
Tidsskr Nor Laegeforen; 1997 Sep; 117(23):3370-3. PubMed ID: 9411890
[TBL] [Abstract][Full Text] [Related]
8. [Autoimmune cholestasis syndrome. Ursodeoxycholic acid is the drug standard].
Stiefelhagen P
MMW Fortschr Med; 2007 May; 149(21):49. PubMed ID: 17668736
[No Abstract] [Full Text] [Related]
9. [Research progress on risk factors for poor response of ursodeoxycholic acid in primary biliary cholangitis].
Yuan Z; Jia G; Han Y
Zhonghua Gan Zang Bing Za Zhi; 2019 Jan; 27(1):73-76. PubMed ID: 30685931
[TBL] [Abstract][Full Text] [Related]
10. Seladelpar in patients with primary biliary cholangitis: Need for a closer look!
Mishra AK; Singh SP
J Hepatol; 2022 Nov; 77(5):1451. PubMed ID: 35594993
[No Abstract] [Full Text] [Related]
11. Ursodeoxycholic acid for the treatment of primary biliary cirrhosis.
Lindor K
N Engl J Med; 2007 Oct; 357(15):1524-9. PubMed ID: 17928600
[No Abstract] [Full Text] [Related]
12. Toward precision medicine in primary biliary cholangitis.
Carbone M; Ronca V; Bruno S; Invernizzi P; Mells GF
Dig Liver Dis; 2016 Aug; 48(8):843-50. PubMed ID: 27324985
[TBL] [Abstract][Full Text] [Related]
13. Prevention of endpoints in primary biliary cholangitis with ursodeoxycholic acid: quantifying the benefit.
Schattenberg JM
Gut; 2020 Aug; 69(8):1377-1378. PubMed ID: 32205421
[No Abstract] [Full Text] [Related]
14. [New name and new treatments for primary biliary cholangitits].
Bossen L; Ytting H; Jepsen P; Hamberg O; Ott P; Grønbæk H
Ugeskr Laeger; 2018 Mar; 180(10):. PubMed ID: 29536837
[TBL] [Abstract][Full Text] [Related]
15. Chronic fatigue should not be overlooked in primary biliary cholangitis.
Shahini E; Ahmed F
J Hepatol; 2021 Sep; 75(3):744-745. PubMed ID: 33640400
[No Abstract] [Full Text] [Related]
16. [Good prognosis in asymptomatic primary biliary cirrhosis].
Lööf L; Lindgren S
Lakartidningen; 2010 May 26-Jun 1; 107(21):1396-8. PubMed ID: 20645617
[No Abstract] [Full Text] [Related]
17. Ursodeoxycholic acid and long-term survival in primary biliary cirrhosis.
Levy C; Angulo P
Am J Gastroenterol; 2004 Feb; 99(2):269-70. PubMed ID: 15046216
[No Abstract] [Full Text] [Related]
18. A 35-year follow-up of a large cohort of patients with primary biliary cirrhosis seen at a single centre.
Floreani A; Caroli D; Variola A; Rizzotto ER; Antoniazzi S; Chiaramonte M; Cazzagon N; Brombin C; Salmaso L; Baldo V
Liver Int; 2011 Mar; 31(3):361-8. PubMed ID: 21059170
[TBL] [Abstract][Full Text] [Related]
19. Primary Biliary Cholangitis-associated Palmar Keratosis.
Usami J
Intern Med; 2021 Sep; 60(17):2877. PubMed ID: 33746168
[No Abstract] [Full Text] [Related]
20. Ursodeoxycholic acid for primary biliary cirrhosis: lesson for the future?
Gluud C; Christensen E
J Hepatol; 2001 May; 34(5):787-8. PubMed ID: 11434634
[No Abstract] [Full Text] [Related]
[Next] [New Search]
